SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001013762-23-002841
Filing Date
2023-10-10
Accepted
2023-10-10 16:15:42
Documents
2
Period of Report
2023-09-29

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1582
2 POWER OF ATTORNEY ea186539ex24_estrella.htm EX-24 7442
  Complete submission text file 0001013762-23-002841.txt   10467
Mailing Address 5858 HORTON STREET, SUITE 170 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET, SUITE 170 EMERYVILLE CA 94608 (510) 318-9098
Estrella Immunopharma, Inc. (Issuer) CIK: 0001844417 (see all company filings)

IRS No.: 861314502 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ESTRELLA IMMUNOPHARMA, INC. 5858 HORTON STREET, SUITE 170 EMERYVILLE CA 94608
Business Address
Wu Fan (Reporting) CIK: 0001996179 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40608 | Film No.: 231318164